Stage

II

III

IV

85.7 ± 7.6

87 ± 7

53.3 ± 23.3

0.46

80 ± 9

73.9 ± 9.2

50 ± 11.2

0.108

Histopathology

Mixed cellularity

Nodular Scleroses

Lymphocytic rich

Lymphocytic Depletion

76.7 ± 7.9

85.7 ± 9.4

100

100

0.568

65.1 ± 8.5

78.6 ± 11

100

66.7 ± 27.2

0.5

Extra nodal Involvement

Absent

Present

91.2 ± 4.9

65.6 ± 12.2

0.036

78.8 ± 7.2

60 ± 11

0.11

Systemic Symptoms

Absent (A)

Present (B)

92.9 ± 6.9

77.9 ± 7.2

0.28

84.4 ± 10.2

67.5 ± 7.4

0.2

Bulky Disease

Absent

Present

93.5 ± 4.4

61.6 ± 13.6

0.015

80 ± 7.3

60.9 ± 10.2

0.09

Number of regions

<4

≥4

83.3 ± 10.8

81.4 ± 6.6

0.963

83.3 ± 710.8

68.5 ± 7.3

0.3

Early response

No

Yes

80.4 ± 7.4

81.3 ± 9.8

0.8

67.7 ± 7.7

81.3 ± 9.8

0.36

RT

No

Yes

30 ± 14.5

93.4 ± 4.7

<0.0001

30 ± 14.5

80.8 ± 6.1

<0.0001